Yonghe Medical Group Co., Ltd. (HKG:2279)
2.110
+0.050 (2.43%)
At close: Jun 5, 2026
Yonghe Medical Group Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,055 | 815 | 450 | 1,334 | 6,314 | 8,288 | |
Market Cap Growth | 66.13% | 81.06% | -66.24% | -78.88% | -23.81% | - |
Enterprise Value | 707 | 727 | 773 | 1,727 | 5,803 | 8,930 |
Last Close Price | 2.11 | 1.57 | 0.87 | 2.43 | 11.53 | 15.20 |
PE Ratio | 12.87 | 9.94 | - | - | - | 57.43 |
Forward PE | 9.77 | 9.41 | - | - | 33.60 | - |
PS Ratio | 0.52 | 0.41 | 0.23 | 0.68 | 3.95 | 3.11 |
PB Ratio | 1.20 | 0.93 | 0.59 | 1.29 | 3.52 | 3.98 |
P/TBV Ratio | 1.24 | 0.96 | 0.62 | 1.32 | 3.61 | 4.08 |
P/FCF Ratio | 1.98 | 1.53 | 2.31 | - | - | 26.41 |
P/OCF Ratio | 1.91 | 1.48 | 1.85 | - | - | 15.44 |
PEG Ratio | - | 0.82 | 0.82 | 0.82 | 0.82 | - |
EV/Sales Ratio | 0.35 | 0.36 | 0.40 | 0.88 | 3.63 | 3.36 |
EV/EBITDA Ratio | 1.75 | 2.76 | 20.10 | - | - | 21.24 |
EV/EBIT Ratio | 5.12 | 5.26 | - | - | - | 29.04 |
EV/FCF Ratio | 1.33 | 1.37 | 3.97 | - | - | 28.46 |
Debt / Equity Ratio | 0.62 | 0.62 | 0.94 | 1.16 | 0.65 | 0.62 |
Debt / EBITDA Ratio | 1.33 | 1.33 | 3.49 | - | 17.63 | 2.32 |
Debt / FCF Ratio | 1.01 | 1.01 | 3.65 | - | - | 4.10 |
Net Debt / Equity Ratio | -0.40 | -0.40 | 0.18 | 0.45 | 0.00 | -0.34 |
Net Debt / EBITDA Ratio | -1.32 | -1.32 | 3.49 | -1.44 | 0.13 | -1.67 |
Net Debt / FCF Ratio | -0.65 | -0.65 | 0.69 | -2.39 | 0.02 | -2.24 |
Asset Turnover | 1.06 | 1.06 | 0.87 | 0.66 | 0.46 | 0.91 |
Inventory Turnover | 20.51 | 20.51 | 11.69 | 8.93 | 6.91 | 12.68 |
Quick Ratio | 1.47 | 1.47 | 1.00 | 0.95 | 2.11 | 2.22 |
Current Ratio | 1.55 | 1.55 | 1.15 | 1.12 | 2.39 | 2.37 |
Return on Equity (ROE) | 9.80% | 9.80% | -27.36% | -43.26% | -5.23% | 11.42% |
Return on Assets (ROA) | 4.53% | 4.53% | -3.65% | -10.64% | -3.29% | 6.53% |
Return on Invested Capital (ROIC) | 18.21% | 13.17% | -11.03% | -31.09% | -11.94% | 13.96% |
Return on Capital Employed (ROCE) | 10.80% | 10.80% | -10.30% | -26.60% | -6.60% | 10.20% |
Earnings Yield | 7.77% | 10.06% | -53.50% | -45.14% | -1.54% | 1.78% |
FCF Yield | 50.38% | 65.22% | 43.24% | -14.57% | -6.25% | 3.79% |
Dividend Yield | 4.27% | 5.39% | - | - | - | 0.61% |
Payout Ratio | - | - | - | - | - | 58.08% |
Buyback Yield / Dilution | 0.13% | 0.13% | 1.01% | 1.36% | -19.23% | -2.65% |
Total Shareholder Return | 4.40% | 5.52% | 1.01% | 1.36% | -19.23% | -2.04% |